Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment

Cite Embed

TGFβ (transforming growth factor-beta) is a pleotropic cytokine with contrasting effects in cancer. In normal tissue and early tumours, TGFβ acts as a tumour suppressor, limiting proliferation and inducing apoptosis. John Marshall discusses the role of TGFβ in cancer, the role of integrins in activating TGFβ in the TME, and the potential benefits of targeting integrins to augment immunotherapies.

Read the Study

Image courtesy of the interviewee

Report Infringement


Leave a Reply

Your email address will not be published. Required fields are marked *

Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access Faculti through your on-campus or proxy IP address. Alternatively, as a Guest, you have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today.
Related Posts

Add the Faculti Web App to your Mobile or Desktop homescreen